Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
(page 56)
3 November 2025
GS Caltex to source carbon‑free steam from Namhae Chemical
Reactivating an idle sulfuric acid plant to generate steam from refinery sulfur; pipeline and plant modifications start next year with commercial supply in 2027 and ~70,000 tCO₂eq/yr reduction.
3 November 2025
Heidelberg Materials Wins Four EU Grants for Decarbonisation Projects
Projects in Belgium, France, Italy, and Poland aim to cut emissions and boost innovation in carbon capture, utilisation, and storage. National support and regulatory frameworks are crucial.
3 November 2025
Ørsted Divests 50% of Hornsea 3 to Apollo
Ørsted sells 50% of Hornsea 3 to Apollo, enhancing capital structure. The deal, worth approx. DKK 39 billion, is set to close by year-end, pending regulatory approval.
3 November 2025
Johnson & Johnson Validates IVL Durability in Complex BTK Cases at VIVA 2025
DISRUPT BTK II study shows IVL's effectiveness in treating calcified lesions, reducing amputations, and improving quality of life for PAD patients.
3 November 2025
Clariant Wins Petrobras Best Suppliers Award for Chemicals
Clariant excels in quality, ESHA, delivery, and contract management, scoring 5.7/6 on Petrobras's Supplier Performance Index, enhancing its reliability and performance.
3 November 2025
SABIC Reports 45% Rise in Q3 2025 Net Income
Q3 revenues hit SAR 34.3B; free cash flow up 81%. MTBE project launched early. 90+ new products introduced. Local content increased by 17%.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
3 November 2025
Takeda's Dengue Vaccine Proven Effective for 7 Years
QDENGA shows long-term safety and efficacy, reducing dengue cases and hospitalizations. Approved in 41 countries, it remains effective across all virus serotypes with no new safety issues.
3 November 2025
Neste Marks Anniversaries: 15 Years in Singapore, 60 Years in Porvoo
Neste's Singapore refinery celebrates 15 years, expanding renewable capacity. Porvoo marks 60 years, pioneering sustainable fuel innovations.
3 November 2025
Roche's Gazyva Shows Significant Disease Reduction in Lupus Study
Phase III study shows Gazyva meets primary and secondary endpoints in SLE, potentially setting a new care standard by targeting B cells and reducing organ damage risk.
31 October 2025
LyondellBasell Q3 2025 Earnings Report
Reported net loss of $890M, EBITDA of $(480)M. Cash from operations at $983M. Continued focus on operational improvements, asset sales, and cash management.
30 October 2025
KazMunayGas 9M 2025 Trading Update
Oil and gas production rose by 10%, while transportation fell by 1.1%. Hydrocarbon processing increased by 11.7%. Notable growth at Tengiz and Karachaganak; slight decline at Kashagan.
30 October 2025
Merck Announces Q3 2025 Financial Results
Sales rose 4% to $17.3B. KEYTRUDA up 10%, GARDASIL down 24%. GAAP EPS $2.32, Non-GAAP $2.58. FDA approved KEYTRUDA QLEX. Acquired Verona Pharma. Full-year sales outlook: $64.5B-$65B.
30 October 2025
bp Advances Bumerangue Discovery Plans in Brazil
bp confirms a large hydrocarbon column at Bumerangue, with appraisal activities set for 2027. Initial results show promising liquid volumes, boosting confidence in the field's potential.
29 October 2025
Johnson & Johnson to Conduct Study Comparing IMAAVY™ and Alternative FcRn Blocker for gMG
The EPIC study will compare IMAAVY™ to efgartigimod in gMG patients, including a treatment-switch arm. Vibrance-MG data shows sustained IgG reduction and disease control in pediatric patients.
29 October 2025
SynPet Technologies Invests €300M in Plastic Recycling Facility at Port of Antwerp-Bruges
The facility will recycle 250,000 tonnes of mixed plastic waste annually into circular naphtha, using SynPet's energy-efficient Thermal Conversion Process. Operational by 2028.
29 October 2025
Merck and Eisai Update on LEAP-012 Trial for Hepatocellular Carcinoma
The LEAP-012 trial showed no overall survival benefit for the treatment, but progression-free survival improved. The study is closed, and further data analysis is ongoing.
29 October 2025
Merck's KEYTRUDA Approved in EU for Treating Resectable LA-HNSCC
KEYTRUDA gains EU approval as the first anti-PD-1 therapy for resectable LA-HNSCC with PD-L1 expression, based on KEYNOTE-689 results.
29 October 2025
Baltic Power Installs Key Offshore Substations
Two offshore substations installed to transmit wind-generated electricity to Poland's grid, with significant local manufacturing involvement. Completion set for next year, providing 1.2 GW capacity.
29 October 2025
UPM Q3 2025: Resilient Performance Amid Weak Markets
Sales and EBIT declined. Strategic reviews and partnerships initiated. Plywood and paper production adjustments. Biorefinery progress. Sustainability recognized. Uncertainty persists.
29 October 2025
Equinor Q3 2025 Financial Results
Adjusted operating income at $6.21B. Production up 7%. Strong cash flow, cost focus, and strategic developments. Dividend set at $0.37/share.
29 October 2025
OMV Boosts Q3 2025 Clean CCS Operating Result by 20% to EUR 1.3 Billion
Fuels and Chemicals drive growth; Energy segment declines. Cash flow up 7%, leverage at 16%. Progress on Borouge Group and Neptun Deep project.
29 October 2025
Neste Q3 2025 Interim Report
Improved Q3 results driven by performance actions and market recovery. Renewable and oil product sales rose, but cash flow was negative. Strategic growth in Rotterdam continues.
29 October 2025
BASF Q3 2025 Earnings Slightly Exceed Market Expectations
Sales fell 3% due to currency effects and lower prices. EBITDA before special items was €1.5 billion. Share buyback program to start in November 2025.
29 October 2025
Ørsted and Worley Sign Long-Term EPCM Agreement
The eight-year deal supports power generation and CCS in Denmark, enhancing energy infrastructure and decarbonization efforts with a focus on safety and sustainability.
28 October 2025
Aramco and GIP Finalize $11 Billion Jafurah Midstream Deal
The Jafurah project will start production by year-end, expanding gas capacity and supporting Saudi Arabia's growth in energy and petrochemicals.
28 October 2025
Merck's KEYTRUDA and WELIREG Combo Improves DFS in RCC Patients Post-Nephrectomy
The LITESPARK-022 trial shows improved DFS with KEYTRUDA and WELIREG in RCC patients. Safety profiles align with previous studies. Results to be shared with regulators.
28 October 2025
Merck and Eisai's WELIREG and LENVIMA Improve PFS in Advanced Renal Cell Carcinoma Trial
The trial showed significant PFS and ORR improvements with WELIREG and LENVIMA in advanced RCC patients post anti-PD-1/L1 therapy, with consistent safety profiles.
28 October 2025
Port of Rotterdam Throughput Declines 2.6% in Q3 2025
Throughput fell due to lower iron ore and mineral oil volumes. Container and renewable fuel throughput rose, highlighting the port's resilience amid European industry challenges.
28 October 2025
Roche's Gazyva Shows Positive Phase III Results in Pediatric Nephrotic Syndrome
Gazyva achieved sustained remission in young nephrotic syndrome patients, reducing steroid use. No new safety issues. Data to be shared with health authorities.
27 October 2025
Rompetrol Rafinare Advances Storage Capacity Investment
Rompetrol Rafinare upgrades tank farms, boosting storage by 20% and enhancing safety and efficiency at Petromidia refinery.
← Previous
Next →
